Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
NDRG4 promoter hypermethylation is a mechanistic biomarker associated with metastatic progression in breast cancer patients.
Jandrey EHF, Moura RP, Andrade LNS, Machado CL, Campesato LF, Leite KRM, Inoue LT, Asprino PF, da Silva APM, de Barros ACSD, Carvalho A, de Lima VC, Carraro DM, Brentani HP, da Cunha IW, Soares FA, Parmigiani RB, Chammas R, Camargo AA, Costa ÉT. Jandrey EHF, et al. Among authors: de barros acsd. NPJ Breast Cancer. 2019 Apr 5;5:11. doi: 10.1038/s41523-019-0106-x. eCollection 2019. NPJ Breast Cancer. 2019. PMID: 30963110 Free PMC article.
Measuring plasma levels of three microRNAs can improve the accuracy for identification of malignant breast lesions in women with BI-RADS 4 mammography.
Pezuk JA, Miller TLA, Bevilacqua JLB, de Barros ACSD, de Andrade FEM, E Macedo LFA, Aguilar V, Claro ANM, Camargo AA, Galante PAF, Reis LFL. Pezuk JA, et al. Among authors: de barros acsd. Oncotarget. 2017 Sep 11;8(48):83940-83948. doi: 10.18632/oncotarget.20806. eCollection 2017 Oct 13. Oncotarget. 2017. PMID: 29137394 Free PMC article.
Intraoperative radiation therapy in early breast cancer using a linear accelerator outside of the operative suite: an "image-guided" approach.
Hanna SA, de Barros ACSD, de Andrade FEM, Bevilacqua JLB, Piato JRM, Pelosi EL, Martella E, da Silva JLF, Carvalho HA. Hanna SA, et al. Among authors: de barros acsd. Int J Radiat Oncol Biol Phys. 2014 Aug 1;89(5):1015-1023. doi: 10.1016/j.ijrobp.2014.04.038. Epub 2014 Jul 8. Int J Radiat Oncol Biol Phys. 2014. PMID: 25035204 Clinical Trial.
Intratumoral heterogeneity of ADAM23 promotes tumor growth and metastasis through LGI4 and nitric oxide signals.
Costa ET, Barnabé GF, Li M, Dias AA, Machado TR, Asprino PF, Cavalher FP, Ferreira EN, Del Mar Inda M, Nagai MH, Malnic B, Duarte ML, Leite KR, de Barros AC, Carraro DM, Chammas R, Armelin HA, Cavenee W, Furnari F, Camargo AA. Costa ET, et al. Oncogene. 2015 Mar 5;34(10):1270-9. doi: 10.1038/onc.2014.70. Epub 2014 Mar 24. Oncogene. 2015. PMID: 24662834